BioMed Research International / 2012 / Article / Tab 2 / Research Article
Vaxjo: A Web-Based Vaccine Adjuvant Database and Its Application for Analysis of Vaccine Adjuvants and Their Uses in Vaccine Development Table 2 Mineral salt adjuvants.
Adjuvant name Number of Vaccines Mechanism Route Licensed Adjumer 1 Immunostimulant Either* No Aluminum hydroxide vaccine adjuvant 62 Vehicle/immunostimulant Parenteral Yes** Aluminum phosphate vaccine adjuvant 50 Vehicle/immunostimulant Parenteral Yes Alhydrogel 13 Vehicle/immunostimulant Either Yes Aluminum vaccine adjuvant*** 14 Vehicle/immunostimulant Parenteral Yes Aluminum potassium sulfate adjuvant 6 Vehicle/immunostimulant Parenteral Yes Amorphous aluminum hydroxyphosphate sulfate adjuvant (AAHSA) 2 Vehicle/immunostimulant Parenteral Yes Adjumer 1 Immunostimulant Either No Calcium phosphate gel 1 Vehicle Parenteral In Europe Calcium phosphate vaccine adjuvant 1 Vehicle Parenteral In Europe DOC/Alum complex 1 Vehicle/immunostimulant Parenteral No Rehydragel HPA 1 Vehicle Parenteral Yes Rehydragel LV 1 Vehicle Parenteral Yes
Notes: *the term “either” means either mucosal or parenteral route. **the term “yes” means that this adjuvant is licensed in the USA. ***shows those aluminum vaccine adjuvants that were used but without more specific details (e.g., using aluminum hydroxide).
